Save the Date: Thursday, 17 October 2024 – Innovarte/KEI side event: Best and worst practices for limitations and exceptions to patent rights

Title: Best and worst practices for limitations and exceptions to patent rights Date: Thursday, 17 October 2024 Time: 13:30 CEST to 15:00 CEST Location: Room B, WIPO Registration link: https://wipo-int.zoom.us/meeting/register/u5Mtf-6vqz0jGdWIE2AObIjgN86Xuy4yqaKi Conveners: Innovarte and Knowledge Ecology International (KEI) On the margins… Continue Reading

KEI Comments on NIH Exclusive License to Autala for Autoimmune Treatment

On September 3, 2024, Knowledge Ecology International (KEI) submitted comments to the NIH regarding the “Prospective Grant of an Exclusive Patent License: Dimethyl Synaptamide for the Treatment of Autoimmune Disorders and Inflammatory Diseases” (89 FR 66730). The Federal Register notice… Continue Reading

KEI Joins Amicus Brief in CIR v. Dept of Labor case on FOIA and Transparency of Government Records

On July 17, 2024, Knowledge Ecology International (KEI) joined Universities Allied for Essential Medicines, Dr. Christopher Morten, and Dr. Reshma Ramachandran in submitting an amicus brief in the case of the Center for Investigative Reporting, et al. v. United States… Continue Reading

KEI Comment to NIST on Transparency of March-in Proceedings

On December 8, 2023, the National Institute of Standards and Technology (NIST) issued a Request for Information regarding the “Draft Interagency Guidance Framework for Considering the Exercise of March-In Rights” (88 FR 85593). Today KEI submitted comments to NIST regarding… Continue Reading

Chile (on behalf of 62 countries) asks for a more transparent, inclusive process for civil society engagement in WHO negotiations of a pandemic treaty

On Monday, 17 July 2023, Chile, on behalf of a group of 62 WHO member states called for a more transparent, inclusive process for civil society engagement in the WHO negotiations of a pandemic treaty at the Intergovernmental Negotiating Body… Continue Reading

Eric Sawyer December 13, 2021 Petition to HHS on Xtandi March-in Case

On December 13, 2021, Eric Sawyer filed this petition with the Department of Health and Human Services, asking to join an outstanding march-in petition on the patents for the prostate cancer drug enzalutamide, sold under the brand name Xtandi by… Continue Reading